Skip to main content
SpringerLink
Log in

Adiponectin increases glucose-induced insulin secretion through the activation of lipid oxidation

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

The expression of adiponectin receptors has been demonstrated in human and rat pancreatic beta cells, where globular (g) adiponectin rescues rat beta cells from cytokine and fatty acid-induced apoptosis. The aim of our study was to evaluate whether adiponectin has a direct effect on insulin secretion and the metabolic pathways involved. Purified human pancreatic islets and rat beta cells (INS-1E) were exposed (1 h) to g-adiponectin, and glucose-induced insulin secretion was measured. A significant increase in glucose-induced insulin secretion was observed in the presence of g-adiponectin (1 nmol/l) with respect to control cells in both human pancreatic islets (n = 5, p < 0.05) and INS-1E cells (n = 5, p < 0.001). The effect of globular adiponectin on insulin secretion was independent of AMP-dependent protein kinase (AMPK) activation or glucose oxidation. In contrast, g-adiponectin significantly increased oleate oxidation (n = 5, p < 0.05), and the effect of g-adiponectin (p < 0.001) on insulin secretion by INS-1E was significantly reduced in the presence of etomoxir (1 μmol/l), an inhibitor of fatty acid beta oxidation. g-Adiponectin potentiates glucose-induced insulin secretion in both human pancreatic islets and rat beta cells via an AMPK independent pathway. Increased fatty acid oxidation rather than augmented glucose oxidation is the mechanism responsible. Overall, our data indicate that, in addition to its anti-apoptotic action, g-adiponectin has another direct effect on beta cells by potentiating insulin secretion. Adiponectin, therefore, in addition to its well-known effect on insulin sensitivity, has important effects at the pancreatic level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451

    Article  PubMed  CAS  Google Scholar 

  2. King GA, Deemer SE, Thompson DL (2012) Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol 49(suppl 1):41–49

    Article  CAS  Google Scholar 

  3. Baratta R, Amato S, Degano C et al (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89(6):2665–2671

    Article  PubMed  CAS  Google Scholar 

  4. Su SC, Pei D, Hsieh CH et al (2011) Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes. Acta Diabetol 48(2):113–119

    Article  PubMed  CAS  Google Scholar 

  5. Kishida K, Funahashi T, Shimomura I (2012) Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin. Endocr Metab Immune Disord Drug Targets 12(2):118–131

    Article  PubMed  CAS  Google Scholar 

  6. Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769

    Article  PubMed  CAS  Google Scholar 

  7. Tomas E, Tsao TS, Saha AK et al (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99:16309–16313

    Article  PubMed  CAS  Google Scholar 

  8. Kharroubi I, Rasschaert J, Eizirik DL, Cnop M (2003) Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 312:1118–1122

    Article  PubMed  CAS  Google Scholar 

  9. Musso G, Gambino R, Biroli G et al (2005) Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 100(11):2438–2446

    Article  PubMed  CAS  Google Scholar 

  10. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J (2004) Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47:249–258

    Article  PubMed  CAS  Google Scholar 

  11. Beylot M, Pinteur C, Peroni O (2006) Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Metabolism 55:396–401

    Article  PubMed  CAS  Google Scholar 

  12. Staiger K, Stefan N, Staiger H et al (2005) Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocrinol Metab 90(12):6707–6713

    Article  PubMed  CAS  Google Scholar 

  13. Wijesekara N, Krishnamurthy M, Bhattacharjee A et al (2010) Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem 285(44):33623–33631

    Article  PubMed  CAS  Google Scholar 

  14. Gu W, Li X, Liu C et al (2006) Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations. Endocrine 30:217–221

    Article  PubMed  CAS  Google Scholar 

  15. Okamoto M, Ohara-Imaizumi M, Kubota N et al (2008) Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 51:827–835

    Article  PubMed  CAS  Google Scholar 

  16. Winzell MS, Nogueiras R, Dieguez C, Ahren B (2004) Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem Biophys Res Commun 321:154–160

    Article  PubMed  Google Scholar 

  17. Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442

    Article  PubMed  CAS  Google Scholar 

  18. Di Paola R, Caporarello N, Marucci A et al (2011) ENPP1 affects insulin action and secretion: evidences from in vitro studies. PLoS ONE 6(5):e19462

    Article  PubMed  Google Scholar 

  19. Andersson U, Filipsson K, Abbott CR et al (2004) AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279:12005–12008

    Article  PubMed  CAS  Google Scholar 

  20. Patane G, Anello M, Piro S et al (2002) Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51:2749–2756

    Article  PubMed  CAS  Google Scholar 

  21. Patane G, Piro S, Rabuazzo AM et al (2000) Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 49:735–740

    Article  PubMed  CAS  Google Scholar 

  22. Marchetti P, Dotta F, Lauro D et al (2008) An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 146(1–3):4–11

    Article  PubMed  CAS  Google Scholar 

  23. Fischer S, Santos AN, Thieme R et al (2010) Adiponectin stimulates glucose uptake in rabbit blastocysts. Biol Reprod 83(5):859–865

    Article  PubMed  CAS  Google Scholar 

  24. Iwabu M, Yamauchi T, Okada-Iwabu M et al (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2 +) and AMPK/SIRT1. Nature 464(7293):1313–1319

    Article  PubMed  CAS  Google Scholar 

  25. Huypens P, Moens K, Heimberg H et al (2005) Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells. Life Sci 77(11):1273–1282

    Article  PubMed  CAS  Google Scholar 

  26. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953

    Article  PubMed  CAS  Google Scholar 

  27. Kadowaki T, Yamauchi T, Kubota N et al (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792

    Article  PubMed  CAS  Google Scholar 

  28. Kantartzis K, Rittig K, Balletshofer B et al (2006) The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 52:1934–1942

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Endocrinology, Department of Clinical and Molecular Biomedicine, Garibaldi-Nesima Hospital, University of Catania Medical School, Via Palermo 636, 95122, Catania, Italy

    G. Patané, N. Caporarello, C. Parrino, D. Sudano, R. Vigneri & L. Frittitta

  2. Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy

    P. Marchetti & L. Marselli

Authors
  1. G. Patané
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Caporarello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Marchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Parrino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Sudano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Marselli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Vigneri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Frittitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Frittitta.

Additional information

Communicated by Guido Pozza.

G. Patané and N. Caporarello contributed equally to the paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patané, G., Caporarello, N., Marchetti, P. et al. Adiponectin increases glucose-induced insulin secretion through the activation of lipid oxidation. Acta Diabetol 50, 851–857 (2013). https://doi.org/10.1007/s00592-013-0458-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-013-0458-x

Keywords

Search

Navigation